Hwang, A.; Rashid, S.; Shi, S.; Blew, C.; Levine, M.; Saha, A.
18F-FDG PET/CT Semiquantitative and Radiomic Features for Assessing Pathologic Axillary Lymph Node Status in Clinical Stage I–III Breast Cancer Patients: A Systematic Review. Curr. Oncol. 2025, 32, 300.
https://doi.org/10.3390/curroncol32060300
AMA Style
Hwang A, Rashid S, Shi S, Blew C, Levine M, Saha A.
18F-FDG PET/CT Semiquantitative and Radiomic Features for Assessing Pathologic Axillary Lymph Node Status in Clinical Stage I–III Breast Cancer Patients: A Systematic Review. Current Oncology. 2025; 32(6):300.
https://doi.org/10.3390/curroncol32060300
Chicago/Turabian Style
Hwang, Anna, Sana Rashid, Selina Shi, Ciara Blew, Mark Levine, and Ashirbani Saha.
2025. "18F-FDG PET/CT Semiquantitative and Radiomic Features for Assessing Pathologic Axillary Lymph Node Status in Clinical Stage I–III Breast Cancer Patients: A Systematic Review" Current Oncology 32, no. 6: 300.
https://doi.org/10.3390/curroncol32060300
APA Style
Hwang, A., Rashid, S., Shi, S., Blew, C., Levine, M., & Saha, A.
(2025). 18F-FDG PET/CT Semiquantitative and Radiomic Features for Assessing Pathologic Axillary Lymph Node Status in Clinical Stage I–III Breast Cancer Patients: A Systematic Review. Current Oncology, 32(6), 300.
https://doi.org/10.3390/curroncol32060300
